BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11394217)

  • 1. Predictors of adverse events after percutaneous transluminal coronary angioplasty in a group of Hispanic patients.
    Padilla AJ; Vega RA; Lladó IJ; Conde JG
    P R Health Sci J; 2001 Mar; 20(1):5-11. PubMed ID: 11394217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: A one-year follow-up study.
    Rizzo M; Barbagallo CM; Noto D; Pace A; Cefalú AB; Pernice V; Pinto V; Rubino A; Pieri D; Traina M; Frasheri A; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):361-7. PubMed ID: 16216722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis.
    Massoudy P; Thielmann M; Lehmann N; Marr A; Kleikamp G; Maleszka A; Zittermann A; Körfer R; Radu M; Krian A; Litmathe J; Gams E; Sezer O; Scheld H; Schiller W; Welz A; Dohmen G; Autschbach R; Slottosch I; Wahlers T; Neuhäuser M; Jöckel KH; Jakob H
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):840-5. PubMed ID: 19327506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lesion-related factors associated with restenosis after percutaneous transluminal coronary angioplasty in the absence of patient-related factors].
    Sakai Y; Tomobuchi Y; Hashizume T; Imanishi T; Tomimoto S; Toyoda Y; Arita M; Hano T; Nishio I
    J Cardiol; 1997 Jan; 29(1):1-6. PubMed ID: 9023673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization.
    Botto N; Andreassi MG; Rizza A; Berti S; Bevilacqua S; Federici C; Palmieri C; Glauber M; Biagini A
    Int J Cardiol; 2004 Sep; 96(3):341-5. PubMed ID: 15301885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score.
    Madan P; Elayda MA; Lee VV; Wilson JM
    Am Heart J; 2008 Jun; 155(6):1068-74. PubMed ID: 18513521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The classification of coronary lesion from Society for Cardiac Angiography and Intervention predicts better results of coronary angioplasty than the one from American College of Cardiology/American Heart Association Coronary Disease].
    Dussaillant GR; Cumsille F; Ramírez A; Pacheco C; Ugalde H; Oyonarte M;
    Rev Med Chil; 2001 Jun; 129(6):605-10. PubMed ID: 11510199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing and correlates of very early major adverse clinical events following percutaneous coronary intervention.
    Jozic J; Orford J; Steinhubl S; Berger P; Hsu A; Topol E
    J Invasive Cardiol; 2008 Mar; 20(3):113-8. PubMed ID: 18316826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of percutaneous transluminal coronary angioplasty and coronary stenting.
    Chen J; Gao R; Cai Q; Yang Y; Qiao S; Qin X; Zhang J; Yao M
    Chin Med J (Engl); 2002 Apr; 115(4):483-6. PubMed ID: 12133279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of complex additional stenosis after primary angioplasty for acute myocardial infarction in medium-term prognosis.
    Timóteo AT; Fiarresga A; Feliciano J; Ferreira R; Gonçalves JM; Ferreira L; Quininha J
    Rev Port Cardiol; 2004 Jun; 23(6):853-64. PubMed ID: 15376732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial outcomes of coronary angioplasty in diabetic patients.
    Srimahachota S; Boonyaratavej S; Udayachalerm W; Buddhari W; Somabutr C; Chayanont D; Ngarmukos P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S437-42. PubMed ID: 11529371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up.
    van Domburg RT; Foley DP; de Feyter PJ; van der Giessen W; van den Brand MJ; Serruys PW
    Eur Heart J; 2001 Jun; 22(11):934-41. PubMed ID: 11428817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality.
    Assali AR; Moustapha A; Sdringola S; Salloum J; Awadalla H; Saikia S; Ghani M; Hale S; Schroth G; Rosales O; Anderson HV; Smalling RW
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):195-9. PubMed ID: 12772238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA Registry.
    Eisenberg MJ; Schechter D; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Del Core M; Duerr R; Garzon PM; Huynh T; Smilovitch M; Sedlis S; Brown DL; Brieger D; Pilote L;
    Am Heart J; 2001 May; 141(5):837-46. PubMed ID: 11320375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
    Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coronary angioplasty in elderly patients].
    Eeckhout E; Stauffer JC; Vogt P; Kappenberger L; Goy JJ
    Praxis (Bern 1994); 1996 Feb; 85(6):168-71. PubMed ID: 8701180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.